Foreskin regeneration: where the science stands
For many circumcised men, regrowing what was lost is the single biggest source of hope. Here is a sober, sourced look at what's real, what's promising, and what's still years away.
AntiCirc is an educational resource. This page is informational and tracks a research programme from public sources — it is not medical advice, and it makes no promises about outcomes or timelines.
Regeneration vs restoration — not the same thing
The single most important distinction. Do not conflate them.
Restoration — available today
Non-surgical foreskin restoration uses gentle, sustained tension — manual tugging or purpose-made devices — to gradually expand the skin you still have, so it once again covers the glans. It is real, it is being done now, and many restorers report meaningful benefits.
What it does not do: regrow the lost nerve-rich tissue — the ridged band and the specialised structures circumcision removes. It expands existing skin; it does not recreate what was cut away.
Start with restorationRegeneration — experimental
Regeneration aims to regrow the actual lost tissue — nerves, the ridged band and specialised structures — using regenerative medicine, rather than stretching what remains. If it works, it would restore tissue that restoration cannot.
The catch: it is experimental and not yet available. As of mid-2026 it lives in the lab and, at most, in preparation for future human trials. It is hope grounded in early science — not a treatment.
What Foregen is doing
The ECM scaffold approach, in plain language.
Foregen is a non-profit pursuing regenerative medicine with a single goal: to regrow a functional foreskin — not merely cover the glans, but restore the tissue itself.
Their approach centres on a decellularised extracellular matrix (ECM) scaffold. In plain terms: take donor foreskin tissue and strip out the cells, leaving behind the natural collagen "scaffold" — the tissue's structural framework — with its shape and architecture intact. That step is called decellularisation.
The scaffold is then re-cellularised: living cells are seeded back into that framework so they can grow into it and rebuild functional tissue. The hope is that this rebuilt tissue can one day be surgically applied to regenerate what circumcision removed.
This is fundamentally different from restoration, which never touches lost tissue — it only stretches existing skin. Foregen's work is aimed at the tissue itself, which is why it is both more ambitious and much earlier-stage.
The approach, step by step
- 1
Decellularise
Strip cells from donor tissue, keeping the collagen scaffold.
- 2
Recellularise
Seed living cells back into the scaffold to rebuild tissue.
- 3
Test
Check the rebuilt tissue biomechanically and for integration.
- 4
Toward trials
Prepare a surgical plan and human clinical trials — the stage still ahead.
Timeline: where things actually are (as of mid-2026)
Drawn from Foregen's own updates, especially the Sept 2, 2025 report [3]. Each item is dated and hedged.
- As of Sept 2, 2025
Tissue recellularisation nearing completion
Foregen reported that preliminary work re-cellularising the decellularised ECM scaffolds was nearing completion — putting living cells back into the collagen framework of donor foreskin tissue.
- As of Sept 2, 2025
First biomechanical testing done
Biomechanical testing of the first batch of recellularised foreskin samples had been carried out — an early check of whether the rebuilt tissue behaves mechanically like real tissue.
- Beginning, ~3–6 month window
"Milestone 4" underway
Foregen's stated final research milestone was set to begin, with an anticipated 3–6 month completion window given at the time. Windows like this in regenerative medicine routinely slip.
- In preparation
Human clinical-trial prep
Foregen reported developing a surgical plan with reconstructive surgeon Dr. Dan Mon O'Dey, partnering with a Contract Research Organization (CRO), and selecting a country in which to run trials.
- Targeted ~2026 — not yet started
Human trials targeted, but not begun
A human clinical-trial start was targeted for around 2026. As of mid-2026, human trials had NOT yet begun. Treat any specific date with caution.
A note on these dates. This timeline reflects Foregen's own public reporting at the time. Human trials were targeted for around 2026 but had not begun as of mid-2026. We track this from public sources — for the current status, verify directly at foregen.org.
The peer-reviewed evidence
One published preclinical study — described honestly.
2025 · MDPI Bioengineering · animal study
A decellularised ECM scaffold for foreskin reconstruction — a preclinical animal study
A 2025 peer-reviewed animal study tested a decellularised extracellular-matrix scaffold designed for foreskin reconstruction. It reported that the scaffold elicited a limited immune response and promoted vascularisation (the growth of new blood vessels into the tissue) and cellular integration [4].
Why this is encouraging: for a scaffold like this to work, the body must accept it rather than reject it, blood vessels must grow in to keep tissue alive, and cells must integrate. A limited immune response with vascularisation and integration is exactly the early signal you would hope to see — it suggests the approach is biologically plausible.
But keep it in proportion. This is an animal study — a preclinical result. It is not proof that the technique works, is safe, or restores function in humans. Preclinical success does not guarantee human success; many promising animal results do not translate. It is a real, hopeful step — and only a step.
Honest expectations
Hope grounded in real science — held to the truth.
- Timelines in regenerative medicine routinely slip. A targeted date is not a delivery date.
- Preclinical success does not guarantee human success. Many animal results do not translate.
- Be wary of anyone promising a firm date, a sign-up, or a treatment you can get now.
- This is hope grounded in real science — not a product you can buy today.
None of this is fearmongering, and none of it is meant to dim genuine hope. The point is the opposite: the science is real and worth following closely. It just deserves to be reported honestly — because a vulnerable community is exactly the one that overpromising hurts most.
Frequently asked questions
Can you regrow a foreskin?
Not yet — not the actual lost tissue. As of mid-2026 there is no available treatment that regrows a foreskin, including its nerves and ridged band. What exists today is non-surgical restoration, which stretches your remaining skin to cover the glans again but does not regrow the specialised tissue that was removed. True regeneration — regrowing the lost tissue itself — is being researched (most prominently by the non-profit Foregen) but remains preclinical and experimental. It is a research programme, not a procedure you can book.
Is Foregen available yet?
No. As of mid-2026, Foregen's regeneration approach is preclinical research and is not available as a treatment anywhere. There is no clinic offering it and no way to sign up as a patient. Foregen has reported lab progress and preparation for future human clinical trials, but a trial had not started as of mid-2026. Be wary of anyone claiming you can get the treatment now.
When will Foregen human trials start?
Foregen has publicly targeted a human clinical-trial start around 2026, and as of their September 2, 2025 update was preparing by developing a surgical plan with a reconstructive surgeon, partnering with a Contract Research Organization, and selecting a country for trials. However, as of mid-2026 human trials had not yet begun, and no confirmed start date is verified here. Timelines in regenerative medicine routinely slip — we would strongly caution against treating any date as certain. For the current status, check Foregen's own updates.
Is regeneration the same as restoration?
No — this is the most important distinction on the page. Foreskin restoration is available today: it uses tension (manual tugging or restoration devices) to gradually expand the skin you still have so it once again covers the glans. It does not regrow lost nerves or the ridged band. Regeneration aims to regrow the actual tissue that was removed — nerves, specialised structures and all — using regenerative-medicine techniques, and it is experimental and not yet available. Confusing the two leads to false expectations in both directions.
Does foreskin restoration regrow nerves?
No. Restoration expands and re-covers existing skin through tension; many restorers report meaningful benefits such as renewed glans coverage, reduced friction and improved comfort, and some report changes in sensitivity over time as the glans is covered again. But restoration does not regrow the specific nerve-rich tissue (such as the ridged band) that circumcision removes. Regrowing that lost tissue is the goal of regeneration research — a separate, experimental field.
What is the scientific evidence behind foreskin regeneration?
The strongest published support so far is preclinical. A 2025 animal study in MDPI Bioengineering tested a decellularised extracellular-matrix (ECM) scaffold for foreskin reconstruction and found it elicited a limited immune response and promoted vascularisation (new blood-vessel growth) and cellular integration. That is an encouraging preclinical result — it suggests the scaffold approach is biologically plausible — but it is an animal study, not proof that the technique works or is safe in humans. Preclinical success does not guarantee human success.
Sources
Tiered honestly. Foregen is the organisation's own reporting on its work; the MDPI study is peer-reviewed.
- 1Advocacy / primary orgForegenForegen — official site (non-profit pursuing foreskin regeneration)
The organisation's own website. Foregen is the primary source for its research programme and goals — read as the org's own reporting on its work, not as independent verification.
- 2Advocacy / primary orgForegenForegen — research updates
Foregen's running log of research updates. This is where the current, live status is reported — verify the latest status here rather than relying on any date on this page.
- 3Advocacy / primary orgForegenForegen update — September 2, 2025
The specific update behind the milestones on this page: recellularisation nearing completion, first biomechanical testing done, Milestone 4 beginning (3–6 month window), and human-trial preparation (surgeon, CRO, country selection).
- 4Peer-reviewedMDPI Bioengineering (2025)Immunogenicity and Integration of a Decellularized Extracellular Matrix-Based Scaffold for the Reconstruction of Human Foreskin: A Preclinical Animal Study
Peer-reviewed preclinical animal study. Reported a limited immune response and promotion of vascularisation and cellular integration for a decellularised ECM foreskin-reconstruction scaffold. Encouraging preclinical evidence — not proof of human efficacy or safety.
- 5Literature indexPubMed (NIH/NLM)PubMed — foreskin regeneration / decellularized scaffolds
Search entry point into the peer-reviewed literature on foreskin regeneration and decellularised scaffolds, for readers who want to check the primary science directly.
We track this from public sources and report only verified facts — no invented dates, results or promises. Foregen's own reporting is labelled as such rather than treated as independent verification. For the live status, verify directly at foregen.org.
Keep reading
Regeneration is the horizon. Restoration is what's real today — and understanding the foreskin itself puts both in context.
Follow the science
The most reliable place to check the current status is Foregen's own updates. We track it here, but they report it first.
Foregen updates